De Novo Orthopedics

Orthopedic Recovery

WingHeal®

Reinforce the repair. Provide the environment to heal.

WingHeal® Bio-inductive Repair

An ultrathin PEEK augment paired with growth-factor–loaded collagen — mechanically reinforcing the tendon repair and providing an environment for cells to grow, in support of conventional repair. Research-stage; no human clinical data yet.

WingHeal bioinductive bone repair

iRehab

Surgery is just the beginning.

iRehab

VAS · PROM · exercise prescriptions · cross-institution continuity — patient-governed post-op recovery; the care team reviews patient-reported information.

Post-surgical recovery infrastructure — 20 PROM instruments, e-consent v2.1, AI-assisted SOAP drafts, §G pain management, cross-institution continuity (patient-governed), open Brief Schema, Family Link for caregivers, and a 117-hospital picker. Designed for both clinical workflow and patient data autonomy.

20 PROM InstrumentsVAS TrackingAI SOAP DraftsE-Consent v2.1§G Pain MgmtCross-Institution ContinuityPatient-Owned ContinuityFamily LinkOpen Brief Schema117 Hospitals

De Novo Resilience

xGrid

No signal? No problem.

xGrid Resilience Infrastructure

When the network goes down, every clinician's phone becomes a workstation and nearby medical stations help each other — care doesn't stop.

Built for civilian hospitals when the network is unavailable — nearby medical stations support each other, every clinician's phone serves as a workstation, on-site equipment can be replaced instantly, and multiple backup communication paths take over. When the network, servers, or even the building itself can't be used, care can continue.

De Novo xGrid is not a medical device. Not cleared by any regulatory agency.

Stations Help Each OtherPhone as WorkstationWorks OfflineLive Transport UpdatesField Station ReadyMulti-path BackupCivilian-FirstOpen Standards

Laisun

See every asset.

Laisun

From hospital inventory to camping gear — scan, track, and never lose sight of what matters.

READY

Pro

Interested in Our Technology?

We welcome discussions about clinical partnerships, research collaboration, or investment opportunities.

Contact Us